Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Vyne Therapeutics Inc.

Clinical trials sponsored by Vyne Therapeutics Inc., explained in plain language.

VYNE Therapeutics Inc. VYNE NASDAQ

Biopharmaceutical company developing treatments for dermatological and inflammatory diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

New gel shows promise for vitiligo, but study halted early

Disease control Terminated

This study tested a gel called VYN201 for people with non-segmental vitiligo, a condition that causes white patches on the skin. The goal was to see if the gel could reduce the size of these patches over 24 weeks. The trial involved 205 adults aged 18 to 75, but it was terminated…

Phase: PHASE2 • Sponsor: Vyne Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC